Please login to the form below

Not currently logged in
Email:
Password:

public health

This page shows the latest public health news and features for those working in and with pharma, biotech and healthcare.

May’s Brexit plan cautiously welcomed by biopharma sector

May’s Brexit plan cautiously welcomed by biopharma sector

Whilst today’s approach depends on agreement from both sides, continued cooperation between the UK and EU on the regulation of medicines is in the best interests of patient and public ... health, ”say ABPI chief executive Mike Thompson and BIA CEO

Latest news

More from news
Approximately 73 fully matching, plus 837 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    The best example is probably Jem Rashbass’successful attempt to consolidate NHS cancer data through the National Disease Registration Service as part of Public Health England. ... Maybe Roche’s $1.7bn acquisition of Flatiron Health is the first foray

  • Advancing women in healthcare Advancing women in healthcare

    Gerberding’s talent as a doctor and a public health leader first became apparent while working at the frontline of the HIV/AIDs crisis in the 1980s, to leading the US ... She trained as an obstetrician and gynaecologist, and then pursed her drive to

  • The true potential of mobile health tech The true potential of mobile health tech

    The true potential of mobile health tech. Are patients willing to adopt digital? ... At the same time, different measures are used in healthcare, social care and public health, making it difficult to compare across these sectors, which is important when

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    unprecedented demand on the health service, as well as a growing population of people living into their 80s and 90s. ... Greater Manchester (GM) is looking to harness data and digital tech to help it tackle some of the big public health problems in the

  • No incentive for a cure No incentive for a cure

    In theory, it should be desirable to get eligible patients on curative treatments very early in order to realise the full public health benefit. ... of healthcare costs across several stakeholders (eg public payers, corporations and individual patients).

More from intelligence
Approximately 3 fully matching, plus 85 partially matching documents found.

Latest appointments

  • New appointments at 90TEN and WA Health New appointments at 90TEN and WA Health

    New appointments at 90TEN and WA Health. The latest movers and shakers from agencies and consultancies. ... Caroline will join Head of Health, Jenny Ousbey to support WA’s ambition to become a major player in the health public affairs and

  • McCann Health promotes Briana Ferrigno to president of McCann Global Health McCann Health promotes Briana Ferrigno to president of McCann Global Health

    She will drive growth and diversification of the agency’s portfolio. McCann Health has promoted Briana Ferrigno to head up its specialist agency - McCann Global Health - as its president. ... years. “She is an innovative communicator who understands

  • Acumen appoints new strategy director Acumen appoints new strategy director

    Independent consultancy Acumen Public Affairs has named Thomas Bols as its new strategy director, a role that will see him focus on reinforcing Acumen’s healthcare practice. ... Bols has also worked in the areas of market access, government affairs,

  • McCann Health appoints Daniel Carucci as global medical director McCann Health appoints Daniel Carucci as global medical director

    Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health ... Over the last seven years he has worked with

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Global communications and marketing firm Edelman has strengthened its health public affairs capabilities with the addition of Alan Maine, who joins as its senior director. ... Maine, who previously served as head of policy and public affairs at Pfizer UK,

More from appointments
Approximately 3 fully matching, plus 58 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics